Figure 2From: Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrationsTime course of the mean number of active lesions on monthly Gd-enhanced brain MRI.Back to article page